Fluconazole pharmacokinetics in burn patients

被引:24
作者
Boucher, BA
King, SR
Wandschneider, HL
Hickerson, WL
Hanes, SD
Herring, VL
Canada, TW
Hess, MM
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA
[2] Univ Tennessee, Dept Plast Surg, Memphis, TN 38163 USA
[3] Univ Wisconsin Hosp & Clin, Dept Pharm Serv, Madison, WI 53792 USA
[4] Parkland Hlth & Hosp Syst, Dept Pharm Serv, Dallas, TX 75235 USA
[5] Univ Pittsburgh, Dept Pharm Practice, Pittsburgh, PA 15213 USA
关键词
D O I
10.1128/AAC.42.4.930
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The pharmacokinetics of fluconazole in nine adult patients with severe (30 to 95% total body surface area) burns were studied. There was no significant difference in half-life (t(1/2)), clearance (CL), or volume of distribution (V) over time in five patients bn days 3 and 8 of the study (P > 0.05). Combined parameter estimates (means +/- standard deviations) for all nine patients for the two study periods were as follows: t(1/2), 24.4 +/- 5.8 h; CL, 0.36 +/- 0.09 ml/min/kg; and V, 0.72 +/- 0.12 liters/kg. These estimates of t(1/2) and CL in burn patients were approximately 13% shorter and 30% more rapid, respectively, than the most extreme estimates reported for other populations.
引用
收藏
页码:930 / 933
页数:4
相关论文
共 31 条
[1]   PHARMACOKINETICS OF TICARCILLIN CLAVULANATE IN SEVERELY BURNED PATIENTS [J].
ADAM, D ;
ZELLNER, PR ;
KOEPPE, P ;
WESCH, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 :121-130
[2]   PHARMACOKINETICS OF SYSTEMICALLY ADMINISTERED ANTIBIOTICS IN PATIENTS WITH THERMAL-INJURY [J].
BOUCHER, BA ;
KUHL, DA ;
HICKERSON, WL .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (02) :458-463
[3]   IMIPENEM PHARMACOKINETICS IN PATIENTS WITH BURNS [J].
BOUCHER, BA ;
HICKERSON, WL ;
KUHL, DA ;
BOMBASSARO, AM ;
JARESKO, GS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (02) :130-137
[4]   Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection [J].
Bourget, P ;
LesneHulin, A ;
LeReveille, R ;
LeBever, H ;
Carsin, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :139-145
[5]   VANCOMYCIN ELIMINATION IN PATIENTS WITH BURN INJURY [J].
BRATER, DC ;
BAWDON, RE ;
ANDERSON, SA ;
PURDUE, GF ;
HUNT, JL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (06) :631-634
[6]  
CHIN T, 1990, PHARMACOTHERAPY, V10, P305
[7]  
DARGENIO DZ, 1997, ADAPT 2 PHARMACKINET
[8]   CLINICAL PHARMACOKINETICS OF FLUCONAZOLE [J].
DEBRUYNE, D ;
RYCKELYNCK, JP .
CLINICAL PHARMACOKINETICS, 1993, 24 (01) :10-27
[9]   CANDIDA INFECTION IN MASSIVELY BURNED PATIENTS [J].
DESAI, MH ;
HERNDON, DN ;
ABSTON, S .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1987, 27 (10) :1186-1188
[10]   BA SIMPLE AND RAPID METHOD FOR DETERMINATION OF FLUCONAZOLE IN HUMAN PLASMA SAMPLES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
FLORESMURRIETA, FJ ;
GRANADOSSOTO, V ;
HONG, E .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1994, 17 (17) :3803-3811